|
 PharmaBioSource Realty, LLC, has been retained by Orchestra Therapeutics, Inc., to transact its King of Prussia Vaccine Facility.
Excellent Opportunity: to acquire the Orchestra Therapeutics cGMP Vaccines Manufacturing Facility in King of Prussia, Pennsylvania (suburban Philadelphia). The facility was designed to develop and manufacture vaccines for clinical Phase I, II and III studies as well as commercial Launch. At this scale, Orchestra Therapeutics has considerable excess capacity and has an interest in selling its assets in King of Prussia or leasing the facility. Inquiries should be sent to PharmaBioSource Realty, LLC.
- 680 Allendale Road
King of Prussia, Pennsylvania
- 3 Acre site located in a professional / industrial park
- 52,000 Square Feet (SF) building
cGMP Vaccine Manufacturing Facility with Laboratories, Office and Support Spaces
- 23,000 SF BSL-3 Vaccine Manufacturing (CDC / NIH)
- designed to manufacture vaccines (mammalian cell culture)
- Validated critical utilities and process equipment…
- BSL-3 Cell Culture Suite (CDC / NIH)
- BSL-3 Downstream Processing Suite (CDC / NIH)
- Aseptic Processing Area for Aseptic Formulation / Filling of syringes
- 5,000 SF Process Development, Microbiology and Analytical Laboratories
- Supports IPC / Lot Release
- BSL-2/3 area for viral bioassays, viral antigen chemistry and ELISA
- GMP utility testing (EM, Water, Pure Steam)
- Validation support
- 6,000 SF Office and Administrative Areas
- Executive and administrative offices as well as technical personnel
office areas
- 18,000 SF Facility Support Spaces
- Process Utilities
- Facility Mechanical Areas
- Materials Storage / Receiving
- Current Lease Term: 3Q 2011 (5 year options)
- Occupancy Limit: 135
|
